Stryker Corporation (LON:0R2S)
London flag London · Delayed Price · Currency is GBP · Price in USD
355.34
-1.47 (-0.41%)
Jan 29, 2026, 5:09 PM GMT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 2011 - 2021
Instruments Revenue
3.18B
Log In
Log In
Log In
Upgrade
Endoscopy Revenue
3.81B
Log In
Log In
Log In
Upgrade
Medical Revenue
4.20B
Log In
Log In
Log In
Upgrade
Neurovascular Revenue
1.97B
Log In
Log In
Log In
Upgrade
Neuro Cranial Revenue
2.49B
Log In
Log In
Log In
Upgrade
MedSurg & Neurotechnology Revenue
15.65B
Log In
Log In
Log In
Upgrade
Knees Revenue
2.66B
Log In
Log In
Log In
Upgrade
Hips Revenue
1.87B
Log In
Log In
Log In
Upgrade
Trauma and Extremities Revenue
3.95B
Log In
Log In
Log In
Upgrade
Spinal Implants Revenue
185.00M
Log In
Log In
Log In
Upgrade
Other Orthopaedics Revenue
815.00M
Log In
Log In
Log In
Upgrade
Orthopaedics Revenue
9.47B
Log In
Log In
Log In
Upgrade
Revenue (Total)
25.12B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 2011 - 2021
United States Revenue
19.01B
Log In
Log In
Log In
Upgrade
International Revenue
6.11B
Log In
Log In
Log In
Upgrade
Revenue (Total)
25.12B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 2011 - 2021
MedSurg & Neurotechnology Operating Income
-
Log In
Log In
Log In
Upgrade
Orthopaedics Operating Income
-
Log In
Log In
Log In
Upgrade
Operating Income (Total)
4.89B
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 2011 - 2021
Organic Net Sales Growth
10.30%
Log In
Log In
Log In
Upgrade
Updated Dec 31, 2025. Data Source: Fiscal.ai.